22nd EAA Congress – 15th ISGA Congress – 5th International Conference of Evolutionary Medicine

This Abstract book covers material of the Joint International Meeting: 22nd EAA Congress, 15th ISGA Congress, 5th International Conference of Evolutionary Medicine. This event was organized at Vilnius University (Lithuania) in 2022 on August 24-27th in a hybrid way, which brought together 28 famous keynote speakers from Austria, Great Britain, the USA, Australia, Croatia, Poland, France, Switzerland, Germany and other countries. This book includes the abstracts of more than 180 presentations. The main theme of the 22nd Congress of EAA (European Anthropology Association) is Human variation and adaptation in a changing world with a particular focus on physical, biopsychosocial and general health changes in the human body. The topics of the 15th Congress of ISGA (International Society for the Study of Human Growth and Clinical Auxology) expand our understanding of human growth and development in health and disease. Special attention is paid to human growth in the period of early ontogenesis, to environmental factors affecting growth (including growth in war and other stressful conditions), children and adolescents’ nutrition and body composition, also modern analyses of growth data. The 5th International Conference on Evolutionary Medicine expands an interdisciplinary approach to understanding the diversity of human health and disease, sharing research from different fields to cooperate together in order to understand the mechanisms of different disease from the evolutionary point of view. The Abstract Book of this joint international event should not only be interesting to scientists of various scientific fields such as anthropology, human biology, public health, and health education, but also to clinical doctors, especially neonatologists, paediatricians, family practitioners and many others. Organisers believe that knowledge of the potential of human adaptation and evolutionary mechanisms in maintaining the health and wellbeing of our species will encourage fruitful interdisciplinary discussions in medical society as well as among biologists, sociologists and other specialists

Early result: randomized controlled trial of treatment for intermittent claudication

Objective: To compare angioplasty (PTA), supervised exercise (SEP) and PTA + SEP in the treatment of intermittent claudication (IC) due to femoro-popliteal disease Methods: Over a 6 years period, 178 patients (108 men, median age 70 years) with angioplastiable femoro-popliteal lesions were randomized to: PTA, SEP or PTA + SEP. Patients were assessed prior to and at 1 & 3 month post treatment. ISCVS outcome criteria (Ankle pressures, treadmill walking distances) and Quality of Life (QoL) questionnaires (SF36 and VascuQoL) were analysed. Results: All groups were well matched at baseline. 21 patients withdrew. Intra group analysis: All groups demonstrated significant clinical and QoL improvements (Friedman test, p < 0·05). SEP (59 patients, 8 withdrew) – 62·7% of patients (n = 32) improved following treatment [20 mild, 9 moderate, 3 marked], 27·4% (n = 14) no improvement and 9·8% (n = 5) deteriorated. PTA (60 patients, 3 withdrew) – 66·6% of patients (n = 38) improved following treatment [19mild, 10 moderate, 9 marked], 22·8% (n = 13) no improvement and 10·5% (n = 6) deteriorated. PTA + SEP (59 patients, 10 withdrew) – 81·6% of patients (n = 40) improved following treatment. [10 mild, 17 moderate, 13 marked], 14·2%% (n = 7) no improvement and 4·0% (n = 2) deteriorated Inter group Analysis: PTA + SEP produce a much greater improvement in clinical outcome measures than PTA or SEP alone, but there was no significant Q0L advantage (Kruskal Wallis test, p > 0·05). Conclusion: SEP should be the primary treatment for the patients with claudication and PTA should be supplemented by a SEP